ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 97 filers reported holding ENDOCYTE INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $23,985,000 | +75.8% | 1,350,481 | +36.6% | 0.01% | +60.0% |
| Q2 2018 | $13,644,000 | +22640.0% | 988,731 | +4997.3% | 0.01% | – |
| Q1 2016 | $60,000 | -27.7% | 19,397 | -6.5% | 0.00% | – |
| Q4 2015 | $83,000 | -46.5% | 20,756 | -38.7% | 0.00% | – |
| Q3 2015 | $155,000 | +47.6% | 33,849 | +67.3% | 0.00% | – |
| Q2 2015 | $105,000 | -92.0% | 20,232 | -89.8% | 0.00% | -100.0% |
| Q2 2014 | $1,313,000 | -44.4% | 199,205 | +101.0% | 0.00% | 0.0% |
| Q1 2014 | $2,360,000 | +124.5% | 99,098 | +0.7% | 0.00% | – |
| Q4 2013 | $1,051,000 | +465.1% | 98,423 | +603.6% | 0.00% | – |
| Q3 2013 | $186,000 | -88.6% | 13,989 | -88.7% | 0.00% | -100.0% |
| Q2 2013 | $1,630,000 | – | 124,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |